Literature DB >> 19150426

A conserved salt bridge in the G loop of multiple protein kinases is important for catalysis and for in vivo Lyn function.

Rina Barouch-Bentov1, Jianwei Che, Christian C Lee, Yating Yang, Ann Herman, Yong Jia, Anastasia Velentza, James Watson, Luise Sternberg, Sunjun Kim, Niusha Ziaee, Andrew Miller, Carie Jackson, Manabu Fujimoto, Mike Young, Serge Batalov, Yi Liu, Markus Warmuth, Tim Wiltshire, Michael P Cooke, Karsten Sauer.   

Abstract

The glycine-rich G loop controls ATP binding and phosphate transfer in protein kinases. Here we show that the functions of Src family and Abl protein tyrosine kinases require an electrostatic interaction between oppositely charged amino acids within their G loops that is conserved in multiple other phylogenetically distinct protein kinases, from plants to humans. By limiting G loop flexibility, it controls ATP binding, catalysis, and inhibition by ATP-competitive compounds such as Imatinib. In WeeB mice, mutational disruption of the interaction results in expression of a Lyn protein with reduced catalytic activity, and in perturbed B cell receptor signaling. Like Lyn(-/-) mice, WeeB mice show profound defects in B cell development and function and succumb to autoimmune glomerulonephritis. This demonstrates the physiological importance of the conserved G loop salt bridge and at the same time distinguishes the in vivo requirement for the Lyn kinase activity from other potential functions of the protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19150426      PMCID: PMC2683036          DOI: 10.1016/j.molcel.2008.12.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  58 in total

1.  Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors.

Authors:  X Zhu; J L Kim; J R Newcomb; P E Rose; D R Stover; L M Toledo; H Zhao; K A Morgenstern
Journal:  Structure       Date:  1999-06-15       Impact factor: 5.006

2.  Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation.

Authors:  V W Chan; F Meng; P Soriano; A L DeFranco; C A Lowell
Journal:  Immunity       Date:  1997-07       Impact factor: 31.745

3.  Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.

Authors:  S R Hubbard
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

4.  Crystal structures of c-Src reveal features of its autoinhibitory mechanism.

Authors:  W Xu; A Doshi; M Lei; M J Eck; S C Harrison
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

Review 5.  Lyn tyrosine kinase: accentuating the positive and the negative.

Authors:  Yuekang Xu; Kenneth W Harder; Nicholas D Huntington; Margaret L Hibbs; David M Tarlinton
Journal:  Immunity       Date:  2005-01       Impact factor: 31.745

6.  The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.

Authors:  J C Williams; A Weijland; S Gonfloni; A Thompson; S A Courtneidge; G Superti-Furga; R K Wierenga
Journal:  J Mol Biol       Date:  1997-12-19       Impact factor: 5.469

Review 7.  Structures of Src-family tyrosine kinases.

Authors:  F Sicheri; J Kuriyan
Journal:  Curr Opin Struct Biol       Date:  1997-12       Impact factor: 6.809

Review 8.  Signal transduction from the B cell antigen-receptor.

Authors:  K S Campbell
Journal:  Curr Opin Immunol       Date:  1999-06       Impact factor: 7.486

9.  Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1.

Authors:  Kenneth W Harder; Cathy Quilici; Edwina Naik; Melissa Inglese; Nicole Kountouri; Amanda Turner; Kristina Zlatic; David M Tarlinton; Margaret L Hibbs
Journal:  Blood       Date:  2004-08-31       Impact factor: 22.113

10.  Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulations.

Authors:  Tai-Sung Lee; Steven J Potts; Hagop Kantarjian; Jorge Cortes; Francis Giles; Maher Albitar
Journal:  Cancer       Date:  2008-04-15       Impact factor: 6.860

View more
  16 in total

1.  Aminoglycoside 2''-phosphotransferase IIIa (APH(2'')-IIIa) prefers GTP over ATP: structural templates for nucleotide recognition in the bacterial aminoglycoside-2'' kinases.

Authors:  Clyde A Smith; Marta Toth; Hilary Frase; Laura J Byrnes; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

2.  Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration.

Authors:  Frank E Kwarcinski; Michael E Steffey; Christel C Fox; Matthew B Soellner
Journal:  ACS Med Chem Lett       Date:  2015-07-13       Impact factor: 4.345

3.  Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organization.

Authors:  Fabrizio Villa; Paola Capasso; Marcello Tortorici; Federico Forneris; Ario de Marco; Andrea Mattevi; Andrea Musacchio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

Review 4.  Mechanisms of drug resistance in kinases.

Authors:  Rina Barouch-Bentov; Karsten Sauer
Journal:  Expert Opin Investig Drugs       Date:  2011-02       Impact factor: 6.206

5.  A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the high-affinity IgE receptor.

Authors:  Michael Poderycki; Yoshiaki Tomimori; Tomoaki Ando; Wenbin Xiao; Mari Maeda-Yamamoto; Karsten Sauer; Yuko Kawakami; Toshiaki Kawakami
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

Review 6.  Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology.

Authors:  Bengt Hallberg; Ruth H Palmer
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

Review 7.  Biochemical mechanisms of resistance to small-molecule protein kinase inhibitors.

Authors:  Ratika Krishnamurty; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

8.  Phosphoinositide and inositol phosphate analysis in lymphocyte activation.

Authors:  Karsten Sauer; Yina Hsing Huang; Hongying Lin; Mark Sandberg; Georg W Mayr
Journal:  Curr Protoc Immunol       Date:  2009-11

9.  PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity.

Authors:  A D Whale; A Dart; M Holt; G E Jones; C M Wells
Journal:  Oncogene       Date:  2012-06-11       Impact factor: 9.867

10.  Functions of the Lyn tyrosine kinase in health and disease.

Authors:  Evan Ingley
Journal:  Cell Commun Signal       Date:  2012-07-17       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.